- This event has passed.
Diagnostics, Antibody Testing and Vaccines: Global Outlook on Life Sciences COVID-19 Advances and Evolving Deal Trends
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team will examine the current global market and industry issues and offer perspectives on what is on the horizon for the life sciences sector and its stakeholders. The program will address:
- The current state of diagnostics, antibody testing and vaccine development, and accelerated pathways for certification, approval, reimbursement and market access
- Considerations for deal structures, key diligence concerns and foreign investment control during this unique time
- Emerging digital solutions, including the development and deployment of digital therapeutics, diagnostics and other tools
- Outlook for life sciences M&A and transformation of industry partnerships during and after COVID-19
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.